Generated by Codex with GPT-5

This summary covers The Economist’s June 20th, 2026 Science & technology / Well Informed article listed in the contents as A cancer breakthrough and published under the headline Has one of cancer's master switches been found?.

Pancreatic cancer is one of medicine’s hardest targets: it is aggressive, often detected late and usually resists immunotherapy. The article argues that a new drug, daraxonrasib, matters because it has produced a rare and meaningful gain against that disease while also pointing toward a broader class of cancer treatments.

Generated by Codex with GPT-5

This summary covers The Economist’s June 20th, 2026 Leaders article listed in the contents under Chinese biotech and published under the headline Wrong prescription.

The article argues that America is in danger of mistaking medical innovation for another battlefield in its technology contest with China. Chinese biotechnology has moved from imitation to genuine discovery, and American drug companies are increasingly licensing Chinese-developed molecules. Some politicians now want to treat that trend as a national-security threat, extending investment restrictions to biotech deals and even asking the Food and Drug Administration to disregard Chinese clinical-trial data.

Generated by Codex with GPT-5

This summary covers The Economist’s June 20th, 2026 By Invitation article by Judith Dada, listed in the contents as Judith Dada on the stakes for Europe in AI and published under the headline How Europe must respond to America's AI warning shot.

The essay argues that Donald Trump’s order forcing Anthropic to block non-Americans from its newest frontier models should jolt Europe out of complacency. For the first time, a government had compelled the withdrawal of publicly released advanced AI from foreign users. Whether the ban lasts is less important than what it revealed: Europe depends on American firms, American infrastructure and American political tolerance for access to the most powerful AI systems.

Generated by Codex with GPT-5

This summary covers The Economist’s June 20th, 2026 Briefing article listed in the contents under Access to AI and published under the headline A bouncer gone berserk.

A Ban That Shows Power And Weakness

The article argues that Donald Trump’s order forcing Anthropic to block foreigners from its most advanced Fable 5 and Mythos 5 models is less a coherent AI strategy than a dramatic proof of American control. Washington may have been trying to punish Anthropic after security concerns about its models, but the result was much larger: allies, companies and governments discovered that access to frontier AI could vanish overnight by political decree.

Generated by Codex with GPT-5

This summary covers The Economist’s June 20th, 2026 Briefing article listed in the contents under Anthropic and published under the headline A test of faith.

The article presents Anthropic not just as another artificial-intelligence startup, but as a company whose moral self-image has become part of its power. Founded by defectors from OpenAI who believed frontier AI needed stricter safeguards, Anthropic built its identity around safety, caution and a quasi-missionary belief that artificial general intelligence could reshape civilization. That stance once made it look like the pious sibling in the AI race. Now that its models are commercially valuable and strategically sensitive, the same posture has put it in direct conflict with the American state.

Generated by Codex with GPT-5

This summary covers The Economist’s June 20th, 2026 Leaders article listed in the contents under Artificial intelligence and published under the headline America's AI power grab.

The article argues that America’s most important new geopolitical asset may not be a carrier group, a reserve currency or a trade route. It may be the ability to decide who can use the most capable frontier AI models. When the Trump administration ordered Anthropic to block non-Americans from its latest Fable and Mythos models, the immediate trigger was a reported jailbreak. The broader message was larger: Washington can turn access to the world’s leading AI systems into an instrument of state power.

Generated by Codex with GPT-5

This summary covers The Economist’s June 13th, 2026 Business article listed in the contents as Rise of the robo-couriers and published under the headline Pavement pioneers.

Delivery robots have long sounded like a city-of-the-future novelty: small machines rolling along pavements, carrying groceries or pizza while pedestrians decide whether to be impressed, annoyed or amused. The article argues that the novelty is becoming a business proposition. In Milton Keynes, a British city better known for roundabouts than futuristic technology, Starship Technologies has built one of the largest markets for autonomous grocery delivery. Its claim is simple and commercially important: small pavement robots can deliver goods more cheaply than human drivers.

Generated by Codex with GPT-5

This summary covers The Economist’s June 13th, 2026 Business article listed in the contents as Apple's second bite and published under the headline A second bite.

Apple’s first attempt to add generative AI to the iPhone was a conspicuous failure. Apple Intelligence, announced in 2024, was supposed to turn Siri into a capable personal assistant with access to a user’s messages, apps and other private information. Two years later, many of those promises remain unfulfilled. Apple is now trying again with a strategy that is less technologically ambitious but potentially more commercially effective: let Google supply the underlying AI models while Apple controls how people use them.

Generated by Codex with GPT-5

This summary covers The Economist’s June 13th, 2026 Business article listed in the contents as Fear the SaaSpocalypse and published under the headline The four SaaSquatches of the apocalypse.

Software-as-a-Service once appeared to be one of technology’s safest business models. A provider could develop an application once, distribute it cheaply over the internet and collect recurring fees from every employee who used it. Artificial intelligence now threatens that formula from four directions: the largest AI laboratories, AI-native startups, companies building their own software and SaaS incumbents trying to reinvent themselves. The industry is not about to disappear, but its most profitable assumptions are becoming much less secure.

Generated by Codex with GPT-5

This summary covers The Economist’s June 13th, 2026 Science & technology column listed in the contents as Well Informed: Anti-ageing balms and published under the headline The chemicals that reduce wrinkles.

The crowded market for anti-ageing skin products borrows heavily from biochemistry, advertising ingredients such as retinoids, antioxidants, peptides and exfoliating acids. Much of the supporting evidence, however, comes from company-funded studies or consumer surveys. Only a smaller group of ingredients has convincing scientific backing, and even those can reduce some visible signs of ageing rather than stop the process.